Implementing mRNA Vaccines in the Fight against Respiratory RNA Viruses

2,142
Total downloads
8,972
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 16 Feb 2024

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies

Violet Ankunda
Joseph Ssebwana Katende
Gerald Kevin Oluka
Jackson Sembera
Claire Baine
Geoffrey Odoch
Peter Ejou
Laban Kato
The COVID-19 Immunoprofiling Team
9 more
Hellen Nantambi

doi 10.3389/fimmu.2024.1325387

1,470 views
1 citation

PERSPECTIVE

Published on 08 Nov 2023

From rejection to the Nobel Prize: Karikó and Weissman’s pioneering work on mRNA vaccines, and the need for diversity and inclusion in translational immunology

Amit Bansal

doi 10.3389/fimmu.2023.1306025

5,888 views
8 citations

ORIGINAL RESEARCH

Published on 02 Nov 2023

Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals

Zoltán Szekanecz
Zoltán Vokó
Orsolya Surján
Éva Rákóczi
Szilvia Szamosi
Gabriella Szűcs
Éva Szekanecz
Cecília Müller
Zoltán Kiss

doi 10.3389/fimmu.2023.1247129

1,085 views
5 citations

BRIEF RESEARCH REPORT

Published on 27 Jul 2023

Response to SARS-CoV-2 initial series and additional dose vaccine in pediatric patients with predominantly antibody deficiency

Megha Tandon
Daniel V. DiGiacomo
Baijun Zhou
Paul Hesterberg
Chen E. Rosenberg
Sara Barmettler
Jocelyn R. Farmer

doi 10.3389/fimmu.2023.1217718

1,399 views
3 citations

Share on

Frontiers in Immunology

Frontiers in Immunology

Vaccines and Molecular Therapeutics

Impact

8,972Topic views
6,347Article views
2,142Article downloads